ARAY Key Statistics, Chart & Performance
The current stock price of ARAY is 0.9866 USD. In the past month the price decreased by -15.68%. In the past year, price decreased by -48.61%.
ARAY Latest News, Press Relases and Analysis
ARAY Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.3 | 210.84B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.82 | 197.86B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.37 | 137.17B | ||
| SYK | STRYKER CORP | 26.52 | 133.55B | ||
| IDXX | IDEXX LABORATORIES INC | 55.44 | 55.82B | ||
| BDX | BECTON DICKINSON AND CO | 13.09 | 53.89B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.4 | 48.33B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.09 | 37.82B | ||
| RMD | RESMED INC | 24.9 | 35.98B | ||
| DXCM | DEXCOM INC | 35.66 | 25.87B | ||
| PODD | INSULET CORP | 64.38 | 20.70B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.41 | 18.29B |
Related stock screener links
About ARAY
Company Profile
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Company Info
ACCURAY INC
1240 Deming Way
Madison WISCONSIN 94089 US
CEO: Joshua H. Levine
Employees: 990
Phone: 16088242800
ACCURAY INC / ARAY FAQ
What does ARAY do?
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
What is the stock price of ACCURAY INC today?
The current stock price of ARAY is 0.9866 USD. The price decreased by -0.16% in the last trading session.
Does ACCURAY INC pay dividends?
ARAY does not pay a dividend.
What is the ChartMill rating of ACCURAY INC stock?
ARAY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for ACCURAY INC?
ACCURAY INC (ARAY) currently has 990 employees.
What is the market capitalization of ARAY stock?
ACCURAY INC (ARAY) has a market capitalization of 111.82M USD. This makes ARAY a Micro Cap stock.
What is the next earnings date for ARAY stock?
ACCURAY INC (ARAY) will report earnings on 2026-02-03.
ARAY Technical Analysis
ARAY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ARAY. ARAY has a bad profitability rating. Also its financial health evaluation is rather negative.
ARAY Financial Highlights
Over the last trailing twelve months ARAY reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 24.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.23% | ||
| ROE | -31.22% | ||
| Debt/Equity | 2.06 |
ARAY Forecast & Estimates
8 analysts have analysed ARAY and the average price target is 3.95 USD. This implies a price increase of 300.62% is expected in the next year compared to the current price of 0.9866.
For the next year, analysts expect an EPS growth of -779.31% and a revenue growth 2.63% for ARAY